✦ LIBER ✦

PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

✍ Scribed by B. Alemayehu; D. Parry; N.M. Engel-Nitz; M. Kulakodlu; F. Nathan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN45 DIFFERENCES IN HEALTH-CARE COSTS F

✍ NM Engel-Nitz; B Alemayehu; F Nathan; D Parry; M Kulakodlu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN118 Impact of Bone Metastases on Qual

✍ G. Hechmati; J. Arellano; I. Haynes; O. Gunther; A. Worsfold; A. Rider 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN120 Quality of Life Among German Pati

✍ J.M. Wolff; V. Donatz; J. Klier; W. Erhardt; R.N. Dass; G. Geiges 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Impact Of Bone Metastases (Bm) On The Hu

✍ Hechmati, G.; Arellano, J.; Haynes, I.; Worsfold, A.; Rider, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCN9 Modeling Lifetime Effectiveness of

✍ M. Lothgren; G. Hechmati; I. Jacobs; Y. Qian; J. Arellano 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

7028 Dasatinib and docetaxel combination

✍ Araujo, J.; Mathew, P.; Armstrong, A.J.; Braud, E.L.; Posadas, E.; Lonberg, M.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB